MOVIPREP® Versus NaP Pivotal Phase III Study

PHASE3CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

March 31, 2003

Conditions
Colonoscopy
Interventions
DRUG

macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate

2L gut lavage solution

DRUG

Sodium Phosphate Solution

1 x 45ml solution, BID

Trial Locations (18)

13915

Hôpital Nord, Marseille Nord Cedex 20

25030

Hôpital Jean Minjoz, Besançon

26216

Centre Hospitalier, Montélimar

31403

Hôpital Rangueil, Toulouse

34000

Centre Hospitalier De Montpellier Hôpital St Eloi, Montpellier

37000

Hôpital Trousseau CHRU, Tours

54511

CHU De Brabois, Vandœuvre-lès-Nancy

59037

Hôpital Huriez, Lille

67091

Hôpital Civil / Clinique Medical B, Strasbourg

69003

Hôpital Edouard Herriot, Lyon

75018

Hôpital Bichat Claude Bernard, Paris

75020

Hôpital Croix Saint Simon, Paris

75379

Hôpital Cochin, Paris

75475

Unité Endoscopies Digestives, Hôpital Lariboisière, 2 rue Ambroise Paré, Paris

87000

Hôpital Dupuytren, Limoges

92700

Hôpital Mourier, Colombes

93370

Centre Hospitalier Intercommunal, Montfermeil

06202

Hôpital De L'Archet, Nice

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Norgine

INDUSTRY